Shih - Wei Wei Wang

Dr. Shih - Wei Wei Wang

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SWShih - Wei Wei Wang
Shih - Wei Wei Wang
LCLeong-Perng Chan
Leong-Perng Chan
LWLing-Feng Wang
Ling-Feng Wang
CWChe-Wei Wu
Che-Wei Wu
SLSheng-Hsuan Lin
Sheng-Hsuan Lin
KLKa-Wo Lee
Ka-Wo Lee
Background: The survival rate of head and neck squamous cell carcinoma (HNSCC) patients with secondary primary malignancy (SPM) showed no significant improvement for decades, however, the impact of advances in diagnostic tools is rarely mentioned. This study investigated the clinical characteristic of HNSCC with SPM over a 27-year period especially from the perspective of diagnostic tools. Methods: This study evaluated 157 HNSCC patients with SPM. The patients were divided into two groups according to the time of SPM diagnosis (Group A:1992–2003; Group B: 2004–2014). Age, gender, stage of first primary malignancy (FPM), SPM interval, overall survival, and disease-free survival were compared between groups. Results: Group B had significantly more SPM developed rate (p = 0.002), more SPM patients with advanced stage of FPM (p = 0.001), synchronous SPM (p = 0.006), and shorter SPM interval (p<0.001) compared to Group A. The survival rate in Group B was not significantly better than Group A. Conclusion: Among patients diagnosed with HNSCC recently, more SPMs are diagnosed in a shorter time interval and in a more advanced stage. The overall advances in diagnostic tools cannot significantly improve SPM survival, however, it enables more patients to receive corresponding treatment.

29 November 2023 in The Kaohsiung Journal of Medical Sciences
Verified
Journal Article
Open access
SWShih - Wei Wei Wang
Shih - Wei Wei Wang
LWLing‐Feng Wang
Ling‐Feng Wang
THTzu-Yen Huang
Tzu-Yen Huang
CTChih-Feng Tai
Chih-Feng Tai

8 January 2024 in Annals of Otology, Rhinology & Laryngology
Verified
Journal Article
Closed access
SWShih - Wei Wei Wang
Shih - Wei Wei Wang
STShu-Yu Tai
Shu-Yu Tai
CCChin-Kuo Chen
Chin-Kuo Chen
KLKuan-Hui Li
Kuan-Hui Li
NCNing-Chia Chang
Ning-Chia Chang
CCChen-Yu Chien
Chen-Yu Chien
Objectives: To investigate the role of normal weight central obesity (NWCO) in the prognosis of sudden sensorineural hearing loss (SSNHL). Methods: We retrospectively investigated 807 cases of SSNHL from January of 2008 to August of 2019 from the Department of Otorhinolaryngology at Kaohsiung Medical University Hospital in southern Taiwan. We analyzed the association between overweight and obesity, NWCO, and the prognosis of SSNHL. The demographic and clinical characteristics, audiometry results, and outcomes were also reviewed. Results: The nonobese (body mass index [BMI] < 24 kg/m 2 ) and overweight and obese groups (BMI ≥ 24 kg/m 2 ) comprised 343 (42.50%) and 464 (57.50%) patients, respectively. The favorable prognosis rates in the nonobese and the overweight and obese groups were 45.48% and 45.91%, respectively, without a significant difference ( P = .9048). Multivariate logistic regression revealed that BMI (adjusted odds ratio [aOR] = 1.00, 95% CI = 0.948-1.062, P = .9165) was not significantly associated with SSNHL recovery. The normal weight noncentral obesity (NWNCO) and NWCO groups comprised 266 (77.55%) and 77 (22.45%) patients, respectively, and had favorable prognosis rates of 48.50% and 35.06%, respectively. The difference between the groups was significant ( P = .0371). Multivariate logistic regression analysis revealed that NWCO (aOR = 2.51, 95% CI = 1.292-5.019, P = .0075) was significantly associated with SSNHL recovery. Conclusions: NWCO may significantly affect the prognosis of SSNHL.

28 February 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
FCFeng-Yu Chiang
Feng-Yu Chiang
KLKang Dae Lee
Kang Dae Lee
KTKyung Tae
Kyung Tae
KJKwang Yoon Jung
Kwang Yoon Jung
CWChih-Chun Wang
Chih-Chun Wang
THTzu-Yen Huang
Tzu-Yen Huang
Background/Objectives: In situ preservation is the primary strategy to preserve parathyroid gland (PG) function during thyroid surgery, while autotransplantation is used when inadvertent removal or devascularization occurs. Deciding on the optimal approach intraoperatively for exposed PGs remains challenging. This study evaluates intraoperative PG management strategies and long-term outcomes of PG function following total thyroidectomy. Methods: This retrospective study included 543 patients undergoing primary total thyroidectomy, excluding those with comorbid parathyroid disease. A stabbing test assessed the vascular supply of exposed PGs. PGs with fresh blood oozing after the test were preserved in situ; otherwise, they were autotransplanted. Intact parathyroid hormone (iPTH) and ionized calcium (iCa) were measured preoperatively and on postoperative day 1 (PO-1D), and during follow-up. Permanent hypoparathyroidism (PHPS) was defined as iPTH < 15 pg/mL, iCa < 4.2 mg/dL, or continued need for calcitriol or calcium supplementation after a postoperative period of 12 months (PO-12M). The PHPS rate was compared with the corresponding intraoperative PG status. Results: A total of 528 patients were enrolled in this study. At PO-1D, 434 patients (82.2%) had iPTH ≥ 15 pg/mL, 65 (12.3%) had iPTH between 4 and 15 pg/mL, and 29 (5.5%) had iPTH < 4 pg/mL. At PO-12M, 527 patients (99.81%) had iPTH ≥ 15 pg/mL, 1 (0.19%) had iPTH between 4 and 15 pg/mL, and none had iPTH < 4 pg/mL. Five patients (0.95%) were in PHPS after PO-12M. Among the 462 patients with at least one viable PG preserved in situ, the PHPS rate was 0.2%, compared to 6.1% (66 patients) for those without a viable PG preserved in situ (p < 0.001). Conclusions: Permanent hypoparathyroidism is rare when at least one viable PG is preserved in situ during total thyroidectomy. The stabbing test is a simple, useful, and cost-effective method to assess the vascular supply of exposed PGs, providing surgeons with essential information for intraoperative PG management.

25 August 2026 in Laryngoscope Investigative Otolaryngology
Verified
Journal Article
Open access
CLChih‐Hao Liu
Chih‐Hao Liu
TLTzu‐Tang Lin
Tzu‐Tang Lin
SWShih - Wei Wei Wang
Shih - Wei Wei Wang
HTHsin‐Yi Tseng
Hsin‐Yi Tseng
WYWing‐Hei Viola Yu
Wing‐Hei Viola Yu
CWChe-Wei Wu
Che-Wei Wu
Objectives: This study aims to investigate the impact of elevated preoperative thyroid autoantibodies, a proposed non‐neural contributor, on postoperative voice outcomes, specifically within a cohort of patients undergoing nerve‐preserved thyroidectomy verified by intraoperative neuromonitoring (IONM). Methods: A retrospective analysis included 212 patients who underwent primary nerve‐preserved thyroidectomy with IONM‐confirmed integrity of recurrent and superior laryngeal nerves. Patients were categorized into elevated antibody (EA) and normal antibody (NA) groups according to thyroglobulin antibody (TgAb) and anti‐thyroid microsomal antibody (TMAb) levels. Objective and subjective voice analyzes (VHI, VRQoL, and IVST) were performed pre‐ and postoperatively. Results: The EA group had a significantly higher proportion of bilateral surgeries, larger tumors, and heavier specimens. Several postoperative voice parameters differed significantly between the two groups, and after adjustment for patient characteristics, EA levels remained independently associated with abnormal shimmer (adjusted OR 2.33, p = 0.021) and abnormal IVST‐T (adjusted OR 2.72, p = 0.010). In the antibody‐grade analysis, a preliminary non‐linear pattern between antibody burden and postoperative voice outcomes was observed in shimmer, IVST‐T, and IVST‐S. Conclusion: In this retrospective exploratory study, elevated thyroid autoantibodies were associated with poorer objective voice stability and greater subjective voice impairment following IONM‐verified nerve‐preserved thyroidectomy. With standardized IONM minimizing the influence of major neural injury, these findings highlight a potential non‐neural influence of thyroiditis on postoperative dysphonia. Shimmer and IVST are useful indicators for detecting subtle functional changes, supporting thyroid antibody status as a practical serological indicator for individualized perioperative counseling and rehabilitation. Level of Evidence: Level III.